First AD

Second AD

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Gynecologic Oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Optimizing Therapy for Endometrial Cancer: Recent Data Highlights

NYU Langone's Perlmutter Cancer Center

Cancer Centers

Partner

Learn about the factors that influence the choice between chemotherapy re-challenge and the combination of lenvatinib and pembrolizumab for endometrial cancer treatment in the context of clinical data. 

Treatment for Recurrent Endometrial Cancer: Chemotherapy or Lenvatinib + Pembrolizumab

Changing Landscape of Endometrial Cancer: Incidence and Classification 

Optimal Workup Strategies in Advanced Endometrial Cancer

Factors in Frontline Treatment Decision Making for Endometrial Cancer

Assessing Response to First-Line Therapy in Advanced Endometrial Cancer: Clinical Factors

Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy  

Treatment Choices for Recurrent dMMR Endometrial Cancer

HER2-Positive Endometrial Cancer: A Targeted Approach to Treatment 

Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab

Revolutionizing Frontline Therapy for Endometrial Cancer: Checkpoint Inhibitors and MMR Status

Expanding Horizons in Endometrial Cancer Treatment: Beyond Chemotherapy 

Diversity and Access to Clinical Trials in Endometrial Cancer 